Corporate Data
| Company name | TOWA PHARMACEUTICAL CO., LTD. |
|---|---|
| Headquarters | 2-11, Shinbashi-cho, Kadoma, Osaka 571-8580 JAPAN TEL:+81(0)6-6900-9100 FAX:+81(0)6-6908-2138 |
| President | Itsuro YOSHIDA |
| Established | June 1951 |
| Incorporated | April 1957 |
| Listing | Prime section of the Tokyo Stock Exchange（TSE） (Securities code :4553) |
| Capital stock | 4,717 million yen (as of end of March 2021) |
| Business operations |
Manufacture and sale of ethical drugs |
| Products | 778 (as of December 2021) |
| Employees | 3,461 (as of April 1st, 2022) |
| Subsidiary company |
J-DOLPH Pharmaceutical CO., LTD. (Manufacture and sale of ethical drugs) Daichi Kasei CO., LTD. (R&D and production of active pharmaceutical ingredients and intermediates) Greencaps Pharmaceutical CO., LTD. (Production of ethical drugs of softcapsules) T Square Solutions CO., LTD. (Delivery and relevant business of IT service associated with healthcare) Towa Pharma International Holdings, S.L. (EU/US Regional Headquarters) Protosera Inc. (Disease risk testing service business and research and development of diagnostic drugs) Sunsho Pharmaceutical Co., Ltd. (Planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods and other miscellaneous merchandizes) |
